Patents by Inventor Jonas Lundahl

Jonas Lundahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF IMPAIRED RESPIRATORY FUNCTION WITH GABOXADOL
    Publication number: 20100093787
    Abstract: The present invention relates to a method for treating impaired respiratory function in a human patient suffering from sleep apnea, such as central sleep apnea or obstructive sleep apnea, comprising administering to said patient an effective amount of gaboxadol per day.
    Type: Application
    Filed: December 11, 2009
    Publication date: April 15, 2010
    Applicant: H. Lundbeck A/S
    Inventors: Jonas Lundahl, Bjarke Ebert, Jan Hedner
  • Treatment of Impaired Respiratory Function with Gaboxadol
    Publication number: 20080269278
    Abstract: The present invention relates to a method for treating impaired respiratory function in a human patient suffering from sleep apnea, such as central sleep apnea or obstructive sleep apnea, comprising administering to said patient an effective amount of gaboxadol per day.
    Type: Application
    Filed: March 31, 2005
    Publication date: October 30, 2008
    Applicant: H. Lundbeck A/S
    Inventors: Jonas Lundahl, Bjarke Ebert, Jan Hedner
  • Treatment of insomnia in human patients
    Publication number: 20050137222
    Abstract: The present invention concerns a method for treating insomnia in a human subject in need thereof by administering to said subject an amount of gaboxadol per day, said amount being effective for the treatment of insomnia. In various preferred embodiments, the effective amount is from 5 to 15 mg gaboxadol in oral dosage form, administered from one hour before up until bedtime.
    Type: Application
    Filed: December 15, 2004
    Publication date: June 23, 2005
    Applicant: H. Lundbeck A/S
    Inventors: Bjarke Ebert, Jonas Lundahl